5종 단미제의 Staphylococcus aureus에 대한 in vitro 항균력 평가

참고문헌 (47)

1. "Mastitis: causes and management" (2000)[URL]
2. Wambach KA, "Lactation mastitis : a descriptive study of the experience", J Hum Lact, 19, pp.24~34 (2003)
3. Nordeng H, "Treatment of mastitis in general practice", Tidsskr Nor Laegeforen, 123(21), pp.3027~3030 (2003)
4. Spencer JP, "Management of mastitis in breastfeeding women", Am Fam Physician, 78, pp.727~731 (2008)
5. Cassat J, "Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390", Microbio, 152, pp.3075~3090 (2006)
6. Kevin P, "Community-acquired methicillin-resistant Staphylococcus aureus : a growing public health problem", Pediatric Health, 1(1), pp.95~105 (2007)
7. Deresinski S, "Methicillin-resistant staphylococcus aureus : an evolutionary epidemiologic and therapeutic odyssey", Clin Infect Dis, 40(4), pp.562~573 (2005)
8. 최성화, "부산지역 설사환자에서 분리한 MRSA 균주의 다양성 분석", 생명과학회지, 18(8), pp.1083~1089 (2008), 한국생명과학회
9. Appelbaum PC, "The fluoroquinolone antibacterials : past, present and future perspectives", Int J Antimicrob Agents, 16, pp.5~15 (2000)
10. Seral C, "Quantitative analysis of gentamicin, azithromycin, telithromycin, Ciprofloxacin, moxifloxacin and oritavancin(LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages", Antimicrob Agents Chemother, 47, pp.2283~2292 (2003)
11. Ackermann G, "Resistant to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutationsin gyrA", Antimicrob Agents Chemother, 45, pp.2348~2353 (2001)
12. Akasaka T, "Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosaisolated in 1998 and 1999 : role of target enzyme in mechanism of fluoroquinolone resistance", Antimicrob Agents Chemother, 45, pp.2263~2268 (2001)
13. Bachoual R, "Single or double mutation alterations of gyrA associated with fluoroquinolone resistance in Carmpylobacter jejuni and Campylobacter coli", Microb Drug Resist, 7, pp.257~261 (2001)
14. 배종국, "한방유방학", pp.153~181 (2005), 정담
15. 한방여성의학 편찬위원회, "한방여성의학Ⅱ", pp.446~449 (2007), 정담
16. 許浚, "東醫寶鑑", pp.681~683 (2006), 동의보감출판사
17. Pfaller MA, "Collaborative investigation of variables in susceptibility testing of yeasts", Antimicrob Agents Chemother, 34, pp.1648~1654 (1990)
18. Janssen AM, "Antimicrobial activity of essential oils: a 1976-86 literature review. Aspects of the test methods", Planta Med, 53, pp.395~398 (1987)
19. Tenover FC, "Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides", J Clin Microbiol, 36, pp.1020~1027 (1998)
20. Cuffini AM, "Enhanced Staphylococcus aureus susceptibility to immuno-defense induced by sub-inhibitory and bactericidal concentration of imipenem", J Antimicrob Chemotherp, 31, pp.559~568 (1993)
21. Almeida RA, "Staphylococcus aureus invasion of bovine mammary epithelial cells", J Dairy Sci, 79, pp.1021~1026 (1996)
22. Menzies BE, "Internalisation of Staphylococcus aureus by endothelial cells induces apoptosis", Infect Immunol, 66, pp.5994~5998 (1998)
23. 정상설, "핵심유방학개론", pp.14~17 (1998), 고려의학
24. 신혁재, "유방염의 최신지견", 의약정보, 37(1), pp.22~27 (2011)
25. 송병기, "한방부인과학", pp.273~274 (1992), 행림출판
26. 대한병리학회, "병리학", pp.1054~1055 (1990), 고문사
27. Fass RJ, "Ciprofloxacin: Best use of this new broad-spectrum antibiotic", Postgrad Med, 87(8), pp.117~131 (1990)
28. K Drlica K, "DNA gyrase, topoisomerase IV, and the 4-quinolones", Microbiol Mol Biol Rev, 61(3), pp.377~392 (1997)
29. Pispirigos K, "Evaluation of cardiac subacute toxicity of Ciprofloxacin in rats using serum biochemical parameters", Arzneimittelforshung, 51, pp.582~587 (2001)
30. Pons R, "Ciprofloxacin-induced vasculitis with cutaneous and renal involvement", Nefrologia, 21, pp.209~212 (2001)
31. Egerbacher M, "Effects of enrofloxacin and Ciprofloxacin hydrochloride on canine and equine chondrocytes in culture", Am J Vet Res, 62, pp.704~708 (2001)
32. Williams RJ II, "The effect of Ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism", Am J Sports Med, 28, pp.364~369 (2000)
33. 김인락, "본초학", pp.186~188 (2007), 영림사
34. 김동현, "한방약리학", pp.223~225 (2006), 신일상사
35. Youn HJ, "Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum", Vet Parasitol, 116, pp.7~14 (2003)
36. 성인화, "白頭翁에서 분리한 Linoleic acid와 시약용 Linoleic acid의 Methicillin-Resistant Staphylococcus aureus와 Candida albicans에 대한 항균효과 비교", 대한화학요법회지, 20, pp.295~302 (2002)
37. Jeon J, "Aqueous extract of the medicinal plant Patrinia villosaJuss. induces angiogenesis via activation of focal adhesion kinase", Microvasc Res, 80, pp.303~309 (2010)
38. Xie Y, "Chemical composition and antioxidant activity of volatiles from Patrinia villosa Juss obtained by optimized supercritical fluid extraction", J Pharm Biomed Anal, 48, pp.796~801 (2008)
39. Li N, "Studies on anti-inflammation chemical constitutes of Patrinia villosa", Zhong Yao Cai, 31, pp.51~53 (2008)
40. 김세령, "지유 에탄올 추출물의 식품 위해성 세균에 대한 항균 활성 및 Salmonella serotype Typhimurium TA100에 대한 항돌연변이 활성 효과", 한국식품조리과학회지, 27(4), pp.17~26 (2011), 한국식품조리과학회
41. Kimura M, "Interaction in the antibacterial activity of flavonoids from Sophora japonica L. to Propionibacterium", Yakugaku Zasshi, 104, pp.340~346 (1984)
42. Cha JD, "Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus", Phytother Res, 23, pp.1326~1331 (2009)
43. Garcia I, "Uptake and intracellularactivity of ofloxacin isomers in human phagocytic and nonphagocytic cells", Int J Antimicrob Agents, 15, pp.201~205 (2000)
44. Gresham HD, "Survival of Staphylococcus aureus inside neutrophils contributes to infection", J Immunol, 164, pp.3713~3722 (2000)
45. Maurin M, "Use of aminoglycosides in treatment of infections due to intracellular bacteria", Antimicrob Agents Chemother, 45, pp.2977~2986 (2001)
46. Navarre WW, "Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope", Microbiol Mol Biol Rev, 63, pp.174~229 (1999)
47. Dziewanowska K, "Fibronectin binding protein and host cell tyrosine kinase are required for internalisation of Staphylococcus aureus by epithelial cells", Infect Immunol, 67, pp.4673~4678 (1999)

관련 논문AI추천